Stay updated on Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Sign up to get notified when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.

Latest updates to the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe revision tag on the page has been updated from v3.6.3 to v3.6.4. This indicates a minor version update rather than a substantive content change.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedPage revision tag updated from v3.6.0 to v3.6.3, indicating a backend update to the page version.SummaryDifference0.1%

- Check46 days agoChange DetectedA recruitment notice 'No longer looking for participants' was added and new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) were introduced. The Intervention/Treatment label was updated from 'Intervention / Treatment' and the revision tag updated to v3.6.0.SummaryDifference0.4%

- Check53 days agoChange DetectedThe page's revision identifier was updated from v3.5.4 to v3.5.5, indicating a small update to the study record rather than a substantive change to the study details.SummaryDifference0.1%

- Check74 days agoChange DetectedA new publication citation was added to the Publications section and the page revision was updated to v3.5.4, replacing the prior v3.5.3 and removing the associated Erratum note.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page’s revision/build label was updated from v3.5.2 to v3.5.3, reflecting a routine ClinicalTrials.gov interface/version change rather than a modification to the study record.SummaryDifference0.1%

Stay in the know with updates to Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.